adsa January 2009

Recombinant Human Soluble RANKL (sRANKL) launched in USA

OYC Americas, Inc. is pleased to announce the launch of recombinant human soluble RANKL (sRANKL) to support osteoporosis and bone metabolism research initiatives. Receptor activator of NF-kB ligand (RANKL), also designated TRANCE, OPGL and ODF, is a member of the … Continue reading

Posted in Press Releases

Announcing OYC Americas, Inc.

Andover, MA. OYC International officially launched its new corporate name and brand image, OYC Americas. This important change is a reflection of our new role and responsibility for the OYC group to expand business and market share in North and … Continue reading

Posted in Press Releases